Access to medicines

Our expertise includes:

• providing research, analysis, policy advice and evaluation
• assisting donors with decision-making around strategic resource allocation, programme design, and implementation and influencing strategies
• capacity building for drug regulation and delivery in the context of building quality health systems

Examples:

• Assessing Global Health Research and Development Financing and Policy Innovations
• A value for money perspective on global health initiative market-shaping activities
• Evaluation of the International Finance Facility for Immunisation (IFFIm)
• External Review of Grant Framework for Public-Private Product Development Partnerships
• UNITAID: Expert Working Group Meeting on Market Impact and Criteria
• Review of the WHO/HAI Africa Regional Collaboration on Access to Essential Medicines in Africa
• Tanzania Pilot ACT Subsidy
• Nigeria: PATHS Programme
• The Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals
• Access to Medicines in Under-served Countries: Intellectual Property Rights, Trade and Drug Registration Policy Implications
• Appraisal of the Affordable Medicines Facility for Malaria (AMFm) Proposal
• Comparative Advantages of Push and Pull Incentives for Technology Development

For more examples of our work in this area search our projects and resources databases.